MedTrace Logo

Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops

NCT05660681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-09-06

No results posted yet for this study

Summary

The primary objective is to evaluate the tolerability and efficacy of CWT-f-002 lubricant eye drops in the treatment of the signs and symptoms of dry eye disease.

Conditions

Interventions

DRUG

glycerin 0.7%/PEG 400 0.3%

Eye drop with active agents from the OTC Monograph.

DRUG

polyethylene glycol 400 0.4%/propylene glycol 0.3%

Eye drop with active agents from the OTC Monograph.

Sponsors & Collaborators

  • Andover Research Eye Institute

    collaborator INDUSTRY

  • Calm Water Therapeutics LLC

    lead INDUSTRY

Principal Investigators

  • Paul Gomes, MS · Andover Research Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2023-08-15
Completion
2023-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05660681 on ClinicalTrials.gov